Tower Research Capital (TRC)’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,660
| Closed | -$3.44K | – | 6192 |
|
|
2024
Q1 | $3.44K | Buy |
1,660
+809
| +95% | +$1.68K | ﹤0.01% | 4866 |
|
|
2023
Q4 | $2.96K | Buy |
+851
| New | +$2.96K | ﹤0.01% | 5145 |
|
|
2022
Q3 | – | Sell |
-57
| Closed | -$11K | – | 6707 |
|
|
2022
Q2 | $11K | Buy |
+57
| New | +$11K | ﹤0.01% | 4408 |
|
|
2022
Q1 | – | Sell |
-17
| Closed | -$12K | – | 6807 |
|
|
2021
Q4 | $12K | Buy |
17
+15
| +750% | +$10.6K | ﹤0.01% | 4355 |
|
|
2021
Q3 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 5338 |
|
|
2021
Q2 | – | Sell |
-14
| Closed | -$19K | – | 6001 |
|
|
2021
Q1 | $19K | Buy |
+14
| New | +$19K | ﹤0.01% | 3940 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | – | – | 5485 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5189 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 5139 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3842 |
|
|
2015
Q4 | – | Hold |
0
| – | -$31K | – | 5225 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1375 |
|
|
2015
Q2 | – | Hold |
0
| – | -$14K | – | 5225 |
|
|
2015
Q1 | – | Hold |
0
| – | -$9K | – | 2546 |
|
|
2014
Q4 | – | Hold |
0
| – | -$14K | – | 2266 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 2604 |
|